Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
Maqola

A robust and interpretable graph neural network-based protocol for predicting p-glycoprotein substrates

Kuang-Cheng HsuDepartment of Computer Science and Information Engineering, National Taiwan University , No. 1, Sec. 4, Roosevelt Rd., Da’an Dist., Taipei City 106319 ,Peihua WangGraduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University , No. 1, Sec. 4, Roosevelt Rd., Da’an Dist., Taipei City 106319 ,Bo‐Han SuYoda, Yoda Therapeutics Inc. , 17 F., No. 3, Yuanqu St., Nangang Dist., Taipei City 115603 ,Yufeng Jane TsengDepartment of Computer Science and Information Engineering, National Taiwan University , No. 1, Sec. 4, Roosevelt Rd., Da’an Dist., Taipei City 106319 ,
ABI

Annotatsiya

P-glycoprotein (P-gp), a key member of the ATP-binding cassette (ABC) transporter family, plays a significant role in drug absorption and distribution by binding to diverse xenobiotics and actively transporting them out of cells. Given P-gp's widespread expression, including its critical presence at the blood-brain barrier, identifying whether a compound functions as a P-gp substrate or inhibitor is essential in drug development to evaluate its ability to penetrate the central nervous system. However, most studies on P-gp focus on inhibitor models rather than substrate models. This study presents a robust graph neural network approach to predict P-gp substrates, leveraging graph convolutional networks, AttentiveFP, and an ensemble model. Using a dataset of 1995 drug molecules (1202 substrates, 793 nonsubstrates), AttentiveFP outperformed traditional methods, achieving an ROC-AUC of 0.848 and an accuracy of 0.815. Integrated gradient analysis identified 20 key substructures associated with P-gp substrates. Most noteworthy is that the top four conferring a >70% probability of substrate classification which can be used a quick assessment in the future. This interpretable framework enhances P-gp prediction and broader drug development efforts.

Hali tarjima qilinmagan

Mavzular

Identifikatorlar

Iqtiboslar va manbalar